SCHEMBL9037772

SCHEMBL9037772

[CH2]CC(O)Oc1ccccc1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.47
KDM4E B2RXH2 2/20 0.47
ALOX15 P16050 2/20 0.44
KMT2A Q03164 5/20 0.41
CYP3A4 P08684 4/20 0.41
CYP2D6 P10635 4/20 0.41
SLC6A2 P23975 3/20 0.41
LMNA P02545 3/20 0.41
MEN1 O00255 3/20 0.41
CHRM1 P11229 2/20 0.41
TSHR P16473 2/20 0.41
ADRA2B P18089 2/20 0.41
HTR2A P28223 2/20 0.41
HTR2C P28335 2/20 0.41
SLC6A4 P31645 2/20 0.41
HRH1 P35367 2/20 0.41
OPRM1 P35372 2/20 0.41
DRD3 P35462 2/20 0.41
OPRK1 P41145 2/20 0.41
HTR2B P41595 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7120232 0.82 CYP1A2 (0.58) CYP1A2KDM4EALOX15KMT2ACYP3A4
SCHEMBL516178 0.82 CYP1A2 (0.49) CYP1A2KDM4EALOX15KMT2ACYP3A4
SCHEMBL10359832 0.81 CYP1A2 (0.47) CYP1A2KDM4EALOX15KMT2ACYP3A4
SCHEMBL515976 0.75 CYP1A2 (0.48) CYP1A2KDM4EALOX15KMT2ACYP3A4
SCHEMBL7774964 0.75 CYP1A2 (0.44) CYP1A2KDM4EALOX15KMT2ACYP3A4
SCHEMBL4527245 0.74 CYP1A2 (0.54) CYP1A2KDM4EKMT2ACYP2D6SLC6A2
SCHEMBL4248685 0.72 CYP1A2 (0.46) CYP1A2KDM4EALOX15KMT2ACYP3A4
SCHEMBL6693445 0.72 ALOX15 (0.46) CYP1A2KDM4EALOX15KMT2ACYP3A4
SCHEMBL31390272 0.72 CYP1A2 (0.46) CYP1A2KDM4EALOX15KMT2ACYP3A4
SCHEMBL16991809 0.72 CYP1A2 (0.46) CYP1A2KDM4EALOX15KMT2ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101039682-A Sulfoalkyl ether-alkyl ether cyclodextrin derivatives UNIV KANSAS (US) 2007-09-19 CN disclosed
EP-0741705-A1 4-(2-(3-ARYLOXY-2-HYDROXYPROPYLAMINO ALKYLOXY)-5-NITROPHENYL)-1,4-DIHYDROPYRIDINES AS ANTIHYPERTENSIVE AGENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-11-13 EP disclosed